Literature DB >> 1972030

Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation.

J M Puck1, K A Siminovitch, M Poncz, C R Greenberg, M Rottem, M E Conley.   

Abstract

Congenital thrombocytopenia may occur in isolation or accompanied by eczema and immunodeficiency, as part of the X-linked hereditary Wiskott-Aldrich syndrome (WAS). Because the clinical and immunologic picture of WAS is variable, particularly early in life, definite diagnosis cannot always be made in cases with a negative family history. Two unrelated males with sporadic congenital thrombocytopenia had only questionable immunologic abnormalities as infants, making them clinically indistinguishable from cases of isolated thrombocytopenia, although one developed episodic neutropenia and the other began to manifest a multisystem autoimmune disease at 2 years of age. Evaluation of X chromosome inactivation in the T cells of both patients' mothers showed each of these women to have the same highly skewed X chromosome inactivation pattern seen in carriers of typical familial WAS. A T-cell defect was subsequently directly demonstrated in the second patient, whose lymphocytes failed to proliferate to periodate and anti-CD43. Taken together, these data suggest the presence of T cell immunodeficiency consistent with WAS in these patients. Furthermore, their mothers were found to have a very high likelihood of being carriers, lending support to the diagnosis of a hereditary disease in these boys and making possible genetic prediction in other family members and subsequent pregnancies.

Entities:  

Mesh:

Year:  1990        PMID: 1972030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency.

Authors:  J M Puck; C C Stewart; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

4.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

5.  X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.

Authors:  G De Saint-Basile; N Schlegel; M Caniglia; F Le Deist; C Kaplan; T Lecompte; F Piller; A Fischer; C Griscelli
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

6.  Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy.

Authors:  Matthew M Wielgosz; Yoon-Sang Kim; Gael G Carney; Jun Zhan; Muralidhar Reddivari; Terry Coop; Richard J Heath; Scott A Brown; Arthur W Nienhuis
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-21       Impact factor: 6.698

7.  A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene.

Authors:  Karolien Beel; Melanie M Cotter; Jan Blatny; Jonathan Bond; Geoff Lucas; Frances Green; Vik Vanduppen; Daisy W Leung; Sean Rooney; Owen P Smith; Michael K Rosen; Peter Vandenberghe
Journal:  Br J Haematol       Date:  2008-11-01       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.